{
    "Trade/Device Name(s)": [
        "Fujirebio Diagnostics Tumor Marker Control",
        "Fujirebio Diagnostics Tumor Marker Controls"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K101809",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082036",
        "K093957"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "October 5, 2010",
    "Summary Letter Received Date": "September 9, 2010",
    "Submission Date": "September 3, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material, Assayed and Unassayed"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "AFP",
        "CA 15-3",
        "CA 19-9",
        "CA 125",
        "CEA",
        "Ferritin",
        "HE4",
        "PSA",
        "Free PSA",
        "CA 242",
        "CA 27.29"
    ],
    "Specimen Type(s)": [
        "Human Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Fujirebio Diagnostics Tumor Marker Control, a quality control serum for monitoring precision in tumor marker laboratory tests.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use as an assayed control serum to monitor laboratory testing precision for AFP, CA 15-3, CA 19-9, CA125, CEA, Ferritin, HE4, PSA, and Free PSA.",
    "fda_folder": "Clinical Chemistry"
}